A Randomized, Double-Blind, Placebo-Controlled Study of Droxidopa for Fatigue in Parkinson’s Disease
Condition(s):Parkinson Disease; Fatigue; ParkinsonismLast Updated:November 23, 2021Terminated
Hide Studies Not Open or Pending
Condition(s):Parkinson Disease; Fatigue; ParkinsonismLast Updated:November 23, 2021Terminated
Condition(s):Parkinson Disease; Falls PatientLast Updated:October 29, 2019Unknown status
Condition(s):Parkinson Disease; Neurogenic Orthostatic HypotensionLast Updated:September 6, 2022Completed
Condition(s):Orthostatic Hypotension; Idiopathic Parkinson DiseaseLast Updated:September 26, 2022Completed
Condition(s):Intradialytic HypotensionLast Updated:June 27, 2014Completed
Condition(s):Symptomatic Neurogenic Orthostatic HypotensionLast Updated:March 20, 2013Completed
Condition(s):QTc IntervalLast Updated:March 7, 2012Completed
Condition(s):Symptomatic Neurogenic Orthostatic Hypotension (NOH); Non-diabetic Neuropathy; Primary Autonomic Failure; Dopamine Beta Hydroxylase DeficiencyLast Updated:May 16, 2014Completed
Condition(s):Orthostatic HypotensionLast Updated:March 13, 2013Terminated
Condition(s):Postural Tachycardia Syndrome (POTS); Vasovagal Syncope (VVS); FaintingLast Updated:April 6, 2022Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.